Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany talks about the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), which will be held in New York in 2017 (http://www.iwcll2017.org/). Prof. Stilgenbauer explains that the program for the iwCLL meeting has just been developed and is very exciting program focusing on the understanding of the disease biology, focusing on the new mutations, the new cancer driver pathways but also on functional interaction with the microenvironment. The meeting will discuss topics that are very relevant not only for disease biology but also as a basis for therapeutic approaches. Further, there will be the talks on new treatment developments, combined treatment modalities and new exciting current developments that are paving the road towards the cure of the disease.
Recorded at the 2016 International Workshop of the German CLL Study Group (GCLLSG) held in Cologne, Germany.